Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | VRTS | RZLV |
|---|---|---|
| Price | $130.91 | $2.08 |
| Change today | ▼ 0.84% | ▼ 3.26% |
| Market cap | $866.98M | $867.09M |
| Return, 3 months | -15.6% | -20.6% |
| Return, year to date | -16.0% | -19.1% |
| Return, 1 year | -27.8% | -66.7% |
| P/E (TTM) | 7.5 | -4.3 |
| P/B | 0.9 | 2.1 |
| P/E percentile vs own 5y | 10th | 29th |
| Dividend yield | 7.22% | – |
| Revenue growth (YoY, latest qtr) | -4.6% | +2,224.2% |
| Net profit growth (YoY) | +4.4% | +41.5% |
| Gross margin | 51.0% | 51.8% |
| Operating margin | 16.0% | -106.6% |
| Net margin | 14.6% | -106.9% |
| Return on equity | 13.0% | -94.4% |
| Analyst target vs. price | +8.7% | +356.7% |
| Analyst buy share | 33% | 100% |
| RSI (14) | 34 | 39 |
| 30-day volatility | 31.3% | 68.5% |
| Max drawdown, 1 year | -33.3% | -69.7% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Sell | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
